Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-24

Clinical Trial Update: Rhinocort Aqua Versus Placebo and Fluticasone Propionate [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Rhinocort Aqua with placebo and with Fluticasone Propionate for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • Rhinocort Aqua (budesonide nasal spray)

Snippet

Sponsor: AstraZeneca | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED